MEnROL: Enhanced Recovery Open Versus Laparoscopic Donor Nephrectomy

Sponsor
Mansoura University (Other)
Overall Status
Completed
CT.gov ID
NCT02699489
Collaborator
(none)
224
2
34

Study Details

Study Description

Brief Summary

A phase III randomized trial conducted to compare recovery outcomes between laparoscopic and open donor nephrectomy within a specified enhanced recovery protocol

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laparoscopic donor nephrectomy
  • Procedure: Open donor nephrectomy
Phase 3

Detailed Description

The MEnROL trial is a phase III randomized controlled trial of Open versus Laparoscopic donor nephrectomy within a standardized enhanced recovery program. Eligible donors were randomized in a 1:1 ratio.

Laparoscopic procedures are performed by a single surgeon (AMM) while Open donor nephrectomies (ODN) were performed by an experienced team that included the laparoscopic surgeon. ODN were performed via a supracostal incision above the 11th rib and an extra-pleural extra-peritoneal approach was adopted. Laparoscopic donor nephrectomy (LDN) was performed via a standard 4-port distribution. Control of the hilar vessels was performed using extra-large Hem-o-Lok clips (Weck- Covidien, Research Triangle Park, NC) and graft extraction was performed via a pre-prepared Pfannenstiel incision.

Donors are enrolled in our enhanced recovery program for donor nephrectomy. The program was compliant with the Enhanced Recovery After Surgery Group (ERAS) guidelines. All donors receive epidural analgesia and are maintained on non-narcotic postoperative analgesics. Criteria for hospital discharge include ambulation, adequate pain control with oral analgesics, and sustained intake of solid food.

Study Design

Study Type:
Interventional
Actual Enrollment :
224 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Mansoura Enhanced Recovery Open Versus Laparoscopic Donor Nephrectomy (MEnROL): A Randomized Controlled Trial
Study Start Date :
Jan 1, 2013
Actual Primary Completion Date :
Jun 1, 2015
Actual Study Completion Date :
Nov 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Laparoscopic donor nephrectomy arm

This group will undergo laparoscopic donor nephrectomy

Procedure: Laparoscopic donor nephrectomy
Laparoscopic donor nephrectomy performed via a standard 4-port distribution. Control of the hilar vessels is performed using extra-large Hem-o-Lok clips (Weck- Covidien, Research Triangle Park, NC) and graft extraction is performed via a pre-prepared Pfannenstiel incision

Active Comparator: Open donor nephrectomy arm

This group will undergo open donor nephrectomy

Procedure: Open donor nephrectomy
Open donor nephrectomy performed via a supracostal incision above the 11th rib and an extra-pleural extra-peritoneal approach was adopted

Outcome Measures

Primary Outcome Measures

  1. Donor recovery as evaluated by the physical fatigue domain of the Multidimensional Fatigue Inventory 20 (MFI-20), [6 weeks]

Secondary Outcome Measures

  1. Short Form-36 (SF-36) health survey [6 weeks]

    Scores of Short Form-36 questionnaire

  2. Length of Hospital stay [up to 2 weeks]

    Length of hospital stay in days

  3. Ischemia times [up to 1 day]

    Warm and Cold ischemia times in minutes

  4. Duration of the procedure [up to 24 hours]

    Duration of the procedure in minutes

  5. Peri-operative complications [90 days]

    Incidence of peri-operative complications in both groups

  6. One year graft loss [1 year]

    Incidence of one year graft loss in both groups

  7. Recipient complications [90 days]

    Incidence of recipient complications in both groups

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Donor aged 18 years or more.

  2. Donors who have the ability to understand information and materials provided.

  3. Donors who didn't express a preference for either open or laparoscopic surgery.

  4. Donors who are fit for both open and laparoscopic intervention

  5. Donors in whom evaluation revealed left kidney with single renal artery suitable for donation.

  6. Donors able to give signed written informed consent.

Exclusion Criteria:
  1. Donors who had a preference for either open or laparoscopic surgery.

  2. Donors in whom the right kidney was chosen for donation.

  3. Donors with double renal arteries in kidneys chosen for donation.

  4. Donors who didn't sign consent.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Mansoura University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
ahmed mansour, Lecturer in Urology, Urology and Nephrology Center, Mansoura University
ClinicalTrials.gov Identifier:
NCT02699489
Other Study ID Numbers:
  • MEnROL
First Posted:
Mar 4, 2016
Last Update Posted:
Mar 4, 2016
Last Verified:
Feb 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes

Study Results

No Results Posted as of Mar 4, 2016